AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2015
Sep 10, 2015
34632_dirs_2015-09-10_b5c34168-96db-4b3c-a5e9-854bfb51992b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2015-09-08
Reporting Person: KOZIN MARC D (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-08 | Common Stock | P | 3000 | $17.60 | Acquired | 14612 | Direct |
More from Tempest Therapeutics, Inc.
Board/Management Information
2026
Jun 4
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 29
Delisting Announcement
2026
May 22
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Regulatory Filings
2026
May 6
Capital/Financing Update
2026
Apr 10
Capital/Financing Update
2026
Apr 10